Elsight Stock Soars on U.S. Defence Win
Elsight (ASX:ELS) closed up 4.3% today at A$6.99, after touching a new all-time intraday high of A$7.33 on news that the company has won one of the most important defence approvals on the ASX. The company’s flagship Halo connectivity platform has been included on the U.S. Department of War’s (formerly Department of Defense) Defense Contract Management Agency (DCMA) Blue List. This is the Pentagon’s directory of approved, NDAA-compliant suppliers for unmanned aircraft systems.
The stock has now run more than 1,600% over the past year and is up around 24% in the past month alone. With a market cap now sitting near A$1.5 billion, the big question for investors looking at it today: Is it too late to buy? In our view, the catalyst is real, but the easy money has been made. Here is what investors need to know.
What the DCMA Blue List Win Actually Means
Getting on the Blue List is not a single contract. It is a gateway. Once a supplier is approved, U.S. defence procurement officers can buy from them without going through the long approval process every time. CEO Yoav Amitai stated that approximately US$75 billion (A$105 billion) is proposed for U.S. drone and counter-drone capabilities in FY2027 alone. That is the addressable market that just opened up.
For comparison, this is similar to the moment DroneShield (ASX:DRO) joined NATO’s first counter-UAS procurement framework. DroneShield’s share price re-rated significantly after that milestone, showing how Pentagon-level approval can transform a small-cap defence stock’s trajectory. Blue List approval gives Elsight a similar institutional standing in U.S. defence procurement, with a clearer path from approval to actual deployment.
The Business Behind The 1,600% Run
The fundamentals support the price action so far. Q1 2026 revenue came in at around US$11.6 million (A$16.8 million), a 12-fold increase on the same quarter last year. It was the fifth consecutive quarter of record revenue. The cash position is strong at US$64 million, with US$3.99 million of net operating cash inflow for the quarter. Elsight is no longer a story stock burning cash. It is now self-funding.
What stands out is the customer base. Of 25 customers in Q1, 17 were repeat orders. That is a strong signal that Halo is being adopted, not just trialled. Recurring software and connectivity revenue grew 11-fold to US$1.3 million, which lifts the quality of earnings as it compounds.
Is Elsight Still A Buy At A$6.99?
For new buyers, we would not chase the stock at today’s levels. After a 1,600% run, the bar for execution is now very high. The afternoon fade from a new all-time high of A$7.33 down to A$6.99 today suggests some investors are already taking profits. Any quarterly miss or contract delay will see sharp downside. The right approach is to build a position on pullbacks rather than chase momentum.
For existing holders, the Blue List win materially strengthens the long-term thesis. We believe the right move is to hold quality and let the U.S. defence runway play out. The U.S. defence drone budget is the strongest tailwind in the ASX small-cap defence space. What to watch next: actual procurement orders flowing from Blue List access, the Phase 3 outcome of the Defense Innovation Unit’s (DIU) Project G.I., and any new partnerships with U.S. defence prime contractors. Each of those would extend the run further.
